ArticleThe annals of applied statistics2023
An extension of estimating equations to model longitudinal medical cost trajectory with Medicare claims data linked to SEER cancer registry.
Article in The annals of applied statistics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Backward joint model for the joint dynamic prediction of time-to-event and longitudinal data: basic formulation and new developments.Lifetime data analysis · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Insurance claims data is an increasingly important health policy research resource, given its longitudinal assessment of cancer care clinical outcomes. Population-level information on medical cost trajectory from disease diagnosis to terminal events, such as death, specifically interests policy makers. Estimating the mean cost trajectory has statistical challenges. The shape of the trajectory is usually highly nonlinear with varying durations, depending on the diagnosis-to-death population time distribution. The terminal event may be right censored, resulting in missing subsequent costs. Medical costs often have skewed distributions with zero-inflation and heteroscedasticity, which may not fit well with the commonly used parametric family of distributions. In this paper, we propose a flexible semi-parametric model to address challenges without imposing a cost data distributional assumption. The estimation procedure is based on generalized estimating equations with censored covariates. The proposed model adopts a bivariate surface that quantifies the interrelationship between longitudinal medical costs and survival, and results in the nonlinear population mean cost trajectory conditional on the death time. We develop a novel generalized estimating equations algorithm to accommodate covariates subject to right-censoring, without fully specifying the joint distribution of the cost and survival data. We provide theoretical and simulation-based justification for the proposed approach, and apply the methods to estimate prostate cancer patient cost trajectories from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database.
Indexed as
Identifiers
40342805PMC12061044What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.